McNeil implements corrective action plan
the McNeil Consumer Healthcare unit of Johnson & Johnson reported that it has taken steps to ensure that similar situations do not happen in the future.
in the NewsFinding Agility in your Workforce: Are you prepared to meet the next market shift? United Airlines and Lufthansa to partner in international cargo operations New trade policies may have negative impact on industrial real estate markets Maximize Your LTL Driver Adherence with Real-time Feedback The Manufacturing Institute, Deloitte and APICS release new study on women in manufacturing More News
In the wake of a product recall that included more than 50 million units of Tylenol arthritis products, St. Joseph's Aspirin, Motrin and other products, the McNeil Consumer Healthcare unit of Johnson & Johnson reported that it has taken steps to ensure that similar situations do not happen in the future. In a letter to the U.S. Food and Drug Administration, Peter Luther, McNeil president, wrote, “McNeil and Johnson & Johnson management are taking this issue very seriously and are committed to ensuring that McNeil implements all necessary corrective and preventive actions to improve the McNeil quality systems.” The letter also outlined key elements of the corrective action plan that includes enhancements to the quality system, organizational changes, and senior management oversight. For more, go to Modern's Web site, mmh.com/recall.
Subscribe to Modern Materials Handling Magazine!Subscribe today. It's FREE!
Find out what the world’s most innovative companies are doing to improve productivity in their plants and distribution centers.
Start your FREE subscription today!
2017 Warehouse/DC Equipment Survey: Investment up as service pressures rise Putaway 101: Everything in its Place View More From this Issue